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ABSTRACT

Microcapsules play an important role in chemical, biomedical, and medical
research. O f importance is their potential use as bio-sensors, as microreactors, and for
drug delivery. In this dissertation, Computational Fluid Dynamics methodology is used to
model the generation o f droplets or cores (using alginate and oil) and to determine from
the model process parameters needed for generating cores o f homogeneous size for the
manufacturing o f microcapsules. Also, material diffusion through a microcapsule for
controlled release is modeled based on finite difference methodology. The model was
applied to experimental data on dextran release from microcapsules in order to estimate
the diffusion coefficients in the core and wall o f a microcapsule.
Results o f the study showed that the velocities o f alginate and oil and their ratio
were considered as two important factors for determining droplet size. One can obtain the
desired droplet size by adjusting these two factors. Also, it was observed that the
properties o f the two immiscible phases can influence the variance. A low viscosity o f
one o f the phases (the non-oil phase) produced a small variance for droplet size. The flow
channel was straight with a width o f 100 micrometers. In future work, it would be o f
interest to determine if channel width and or geometry will have any effect on droplet
size and variance.
Analysis o f diffusivity estimates for the core and wall membrane from fitting the
diffusion model to experimental data on the release o f dextran from microcapsules over
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time revealed that only layer thickness had an effect on diffusivity in the core. The
diffusivity for four layers was almost half o f that for two layers o f polyelectrolytes in the
wall membrane. In the case o f diffusivity in the microcapsule wall, both time and layer
thickness had an effect. Diffusivity was larger for two layers o f wall membrane thickness
than for four or six layers and it was also larger for 12 hours than for 36 or 60 hours of
loading time.

There was no significant change in diffusivity beyond four layers or

beyond 36 hours o f loading time. In all cases, diffusivity in the wall membrane was
considerably less than that in the core.
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CHAPTER 1

INTRODUCTION

1.1 General Overview
Microcapsules

are

hollow

microspheres

encapsulated by

multilayers

of

polyelectrolytes. Considerable number o f studies has been done on microcapsules
because o f its wide application. There are many applications o f microcapsules in
chemical, biomedical, and medical research. Interestingly they can also be used in many
other areas, such as agriculture, the environment, and the automotive industry.
Various techniques and methods have been utilized in the manufacturing and
applications o f microcapsules. O f interest is to determine the factors that affect the size
o f a microcapsule during the manufacturing process as well as its characteristics for a
given application process so that one can optimize both processes.

1.2 Research Objectives
Layer-by-layer

adsorption

of

oppositely

charged

polyelectrolytes,

poly

(styrenesulfonate) PSS and poly (allylamine) PAH, is used as an encapsulating technique
in the manufacturing o f microcapsules. By using this kind o f self-assembly technique,
generated microsphere core material can be encapsulated with PSS or PAH multilayers

1
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2
after which the core is dissolved to obtain the hollow microcapsules. In order to study the
release properties, the hollow microcapsules are loaded with fluorescein-isothiocyanate
(FITC) labeled dextran o f different molecular weights for different lengths o f time, and
then immersed into water where the concentration o f dextran is measured over time. .
Generating cores o f a certain homogeneous size and shape that can be dissolved
after encapsulation is essential for the building o f the microcapsules. Also, understanding
the diffusion properties o f the microcapsule is important for its use in controlled release
studies for drug delivery. Hence, the objectives o f this dissertation are two fold. First, to
model the generation o f alginate droplets or cores using Computational Fluid Dynamics
(CFD) methodology in order to determine the parameters necessary for optimizing
droplet size and for minimizing its variance. Second, to model the diffusion properties o f
microcapsules using a 3-D diffusion model in spherical coordinates and to apply the
model to experimental observations on dextran release in order to estimate the diffusion
coefficients in the core and wall o f the microcapsules. This enables one to determine how
diffusion relates to microcapsule characteristics such as wall thickness, polyelectrolyte
type, loading time o f dextran into the microcapsule, and the molecular weight o f dextran.

1.3 Organization
Chapter One presents a brief introduction o f microcapsules and the research
objectives. Chapter Two gives a literature review o f microcapsules, droplets or cores
generation o f microcapsules, and release studies o f microcapsules. Chapter Three
introduces the experimental procedure o f droplet generation and describes the model o f
droplet generation, the Computational Fluid Dynamics theory behind it. Chapter Four
describes results and the statistical method to optimize the simulation results. Chapter

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3
Five introduces the experimental procedure o f transport phenomena, the model o f release
study, applied numerical analysis and model-checking methodology. Chapter Six
describes simulation results and discussion.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER 2

LITERATURE REVIEW

2.1 Microcapsules
A microcapsule is generally composed o f a core material encapsulated by shell
material that acts as a microcapsule wall. Microencapsulation is a very useful technique
because of the semi-permeability o f the microcapsule wall. The wall can protect the inner
material from the outer environment or can control its release. Microcapsules play an
important role in chemical, biomedical, and medical research. O f importance is their
potential use as bio-sensors, microreactors, microcarriers or as drug delivery vehicles
(Tong, 2006; Chen, 2006). For instance, Ghan (2004) used polyelectrolyte microcapsules
as reactors for synthesizing bio-polymers. Sun et al. (2003) used an ultra thin shell to
encapsulate hepatocytes and showed that the obtained microcapsules had enhanced
differentiated functions over cells cultured in monolayers. Microcapsules can be used
also in many other areas such as bioremediation o f ground water and soil, herbicides,
insecticides, fertilizers (Shigemi and Yoshikawa, 1994), air bag applications in
automotive, bath salt fragrance in cosmetic and personal care, and even sunscreen
products containing said microcapsules (Lahmani, 1996).
Because o f their wide applications, considerable research in science and
engineering has been devoted to microcapsules. Thanks to the technique o f layer-by-layer

4
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assembly o f oppositely charged polyelectrolytes (Lvov, 1993; Hong, 1993; Decher, 1997;
Sukhorukov, 2000; Lvov, 2001; Tong, 2006), multilayer microcapsules prepared by selfassembly onto removable colloidal particles have generated considerable scientific
interest. These hollow capsules have shown potential applications as drug delivery
vehicle, biosensors, microreactors, and microcarriers.

2.2 Droplet Generation
2.2.1 Microfluidic Devices
Because certain fluid properties, such as surface tension, wall adhesion, and
energy dissipation, dominate at the microlevel, microfluidic devices are finding
increasing applications as analytic systems, biomedical devices, tools for chemistry and
biochemistry, and systems for fundamental research (McDonald, 2000; Thorson, 2001;
Thwar, 2005). A microfluidic system was designed and fabricated by Prevot et al. (2003)
to study the behavior o f polyelectrolyte microcapsules flowing in microchannels.
Microfluidic devices were etched in glass and silicon by using conventional methods and
equipments (McDonald, 2000). Conventional equipments have a disadvantage in the
sense that turbulence cannot be controlled or generated consistently throughout the
volume o f the liquid. Hence, compared with conventional methods and processes,
microfluidic devices show superior performance. In this dissertation, a microfluidic
device (capillary system) is utilized to generate alginate microdroplets.
2.2.2 Methodologies
Microdroplets are prepared by various processes. Before the wide use of
microchannels, microdroplets were generated through a microporous membrane and jet
pinch-off. In membrane emulsification, the droplets are formed through the pores at the

5
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surface of the membrane because o f the inner and outer stress difference. Pore size o f the
membrane, pressure of the disperse phase, and adsorption kinetics o f the emulsifier
influence the results o f emulsification (Schroder, 1998). Caused by the interfacial tension
between two immiscible phases, microdroplets are generated by jet pinch-off technology.
Variables include nozzle size, flow rate, and type and concentration o f the phases
(Meister, 1969; Skelland; 1989; Webster, 2001). A microcapsule generating system
containing an air knife was used to form spherical microcapsules containing tissue or
living cells (Dorian, 1996; Dorian, 1996). A vibrating orifice aerosol generator (VOAG)
was used by Ray et al. (2005) to generate droplets with a small size variation. The
droplets were dispersed in air to prevent agglomeration. The generation o f tailored
microspheres can be achieved using this technique. These particles are microspheres o f
polymeric materials manufactured by in-situ photopolymerization o f droplets containing
monomers and additives. The important factors using this technique are: the pressure
used to generate monodisperse droplets through a VOAG, the vibration frequency o f the
orifice, the surrounding gas temperature, and the dispersion air.
Recently, microchannels have been used for generating microdroplets in
microfluidic devices. Emulsions are formed by shearing one liquid into another
immiscible liquid, often in the presence o f a surfactant, to create small droplets. These
droplets are formed by forces generated at the leading edge o f the two liquid phases.
Results o f the emulsification process can be described by the mean droplet size and the
variance o f the droplet size. Among other parameters, flow rates o f the two phases,
viscosity o f the two phases, and geometry o f the microchannel can influence the
emulsification significantly (Lister, 1998; Thorson, 2001; Tan, 2004). Droplets formed

6
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by the co-flow o f oil and water through a T-shaped microchannel have been studied by
several groups (Thorson, 2001; Collins, 2003). Droplet generation has been studied in Dr.
Palmer’s Laboratory at Louisiana Tech University. They used a T-shaped channel
microfluidic device with a bifurcating junction to generate alginate droplets. Alginate is
sheared by a continuing phase, vegetable oil.
2.2.3 Alginate Microdroplets
Alginate, used in the generation o f microdroplets or spheres, is derived from
seaweed which is a salt o f alginic acid. Alginate is widely used in many areas because o f
its mild gelling, biocompatibility, and biodegradability. For instance, alginate is the most
popular material for the formation o f the polymer matrix and outer biocompatible
membrane. Purified alginate was used to coat cell or tissue transplants (Dorian, 1996).
Sodium alginate can be used in the food industry as an emulsifier, thickener, stabilizer, or
gel-forming agent like agar and carrageenan (Ragaza, 1999). Wheatley (1991) attempted
to form microparticles from sodium alginate in a 1/3 % buffered calcium chloride
solution. Also, sodium alginate-chitosan (AC) microcapsules were used by Yu (2006) as
immobilization carriers for cell culture. Ma et al. (2005) provided a method for preparing
sodium alginate-polylysine microcapsules which contain immobilized yeast cells.
Calcium alginate is a traditional method to fix bone splitters. As a general therapy,
calcium alginate is administered as a nutrient additive 1-2 times a day in addition to diet.
Orive et al. (2006) created alginate-PLL-alginate (APA) microcapsules using an
electrostatic droplet generator. The alginate-poly-L-lysine-alginate membrane is widely
used in cell encapsulation. Chen (2006) successfully used these APA microcapsules to
limit the major immuno-rejection problems related to the use o f live cells and bacteria in

7
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some animal models. Li et al. (2005) attempted to evaluate the function o f porcine islets
encapsulated by APA. APA microencapsulated porcine islets were able to secrete insulin
both in vitro and under a perfusion condition. The porcine islets showed the ability to
secrete insulin in a culture medium o f different glucose concentrations. It was shown that
both in vitro and in vivo APA microencapsulated porcine islets can maintain their
function and therapeutic effect. Sun et al. (2002) used an electrostatic droplet generator
(EDG) technique to prepare APA microcapsules and study the thickness o f the
polyelectrolyte

APA

microcapsule

membrane.

Glucose

oxidase-doped

alginate

microspheres encapsulated with calcium chloride added for ionic gelation were produced
for enzymic sensors using water-in-oil emulsion (McShane, 2005). Monodisperse
calcium alginate microparticles were studied in this research. These microcapsules can be
used as vehicles to carry sensing material into the human body. The optimum size o f the
microparticles for implanting in the transderma layer was about 40-50 pm.

2.3 Laver-bv-laver Encapsulation
Microcapsules prepared by the deposition o f alternate layers o f crosslinked
atelocollagen and polyholosides are biocompatible by virtue o f the presence o f
atelocollagen. Atelocollagen with a very low antigenicity and a perfect biodegradability
has most o f the advantageous properties o f collagen (Levy, 1997). Ijichi (1997) was
successful in obtaining spherical gelatine/acacia microcapsules with thicker membrane by
using the conventional complex coacervation method.

Double layered microcapsules

were made by Yamamoto and Sefton (1996) using vinyl amine copolymer films. Those
microcapsules can perform polymer grafting reactions without damaging cells inside the

8
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microcapsules. Takiguchi et al. (2004) developed technology for discharging and
microencapsulating minute amounts o f droplets.
Polyelectrolyte multilayer microcapsules are microcapsules with the walls made
o f polyelectrolyte

multilayers.

Layer-by-layer

assembly

o f oppositely

charged

polyelectrolyte onto removable colloidal particle surfaces has been used by many groups
because o f its potential application (Radtchenko, 2000; Antipov, 2002; Tong, 2006).
Voigt (1999) reported on the use o f nonsol. Polystyrene sulfate latex, solution melamine
formaldehyde resin latex, and decomposable glutaraldehyde-fixed human red blood cells
as target particles for layer-by-layer adsorption. Zhao et al. (2006) and Gao et al. (2006)
showed how the structure and stability o f polypeptide multilayer films can affect various
types o f noncovalent interactors. Rilling et al. (1997) used polycation/polyanion double
layers to encapsulate cytochrome C. The layer-by-layer assembly technique was used to
construct various types o f POM-polyelectrolyte composite microcapsules because o f the
versatile properties o f polyoxometalate (POM) (Gao, 2005). For the layer-by-layer self
assembled polyelectrolyte microcapsules, a magnetic field can be used to modulate the
permeability (Lu, 2005; Prouty, 2004).
At the Institute for Micromanufacturing (IFM), Louisiana Tech University, poly
(styrene sulfonate) (PSS) and poly (allylamine) (PAH) are the two polyelectrolytes used
in layer-by-layer encapsulation o f microsphere colloidal core material (melamine formal
dehyde (MF)) to obtain multilayer microcapsules. Pargaonkar (2005) showed that the
release phenomena can be controlled by the component and the number o f layers. A
composition o f a sustained release layer and a fast release layer was also used in order to
optimize microcapsules for controlled release.

9
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2.4 Transport Phenomena
“The main focus in the area o f emulsion technology is to improve stability and
control the release o f active matter in double emulsions” (Lyon, 2002). Because o f the
permeability property o f a microcapsule’s wall, microencapsulation is an important
technique used to protect the inner materials from the outer environment or to control the
release of the encapsulated inner materials. Studies o f mass transport in microcapsules
are important for microcapsule applications. Microcapsules have potential applications in
drug delivery, as biosensors, microreactors, or microcarriers.
Setterstrom et al. (1982) developed microcapsules that can maintain slow release
o f effective therapeutic doses o f antibiotics in a wound over a 14-day period.

Polk

(1994) used semi-permeable biocompatible microcapsules to entrap a vaccine in order to
destruct the fish digestive system. It was showed that controlled-release formulations can
provide a short half-life “pulsed” plasma profile o f a sedative-hypnotic compound.
Research on anticancer drug doxorubicin hydrochloride (DOX) in a drug delivery system
was undertaken by Yang et al. (2005), Khopade et al. (2002), and Liu et al. (2005).
Benichou et al. (2004) attempted to select food-grade blends o f emulsifiers to enhance
emulsion stability at both inner and outer interfaces. They used new polymeric
amphiphiles (carriers, complexing agents, natural polymeric emulsifiers) in order to
control and reduce the reverse micellar transport phenomena and to control the transport
the inventive method and associated device was used by Windhab (2005) to obtain multi
microcapsules. These microcapsules are adapted to different substance components and
release conditions.
In so many applications o f microcapsules, a critical question is how to control the
transport phenomena. From research in the literature, it is clear that the permeability o f a
10
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microcapsule depends on the type and thickness o f the wall, loading time o f the inner
material, pH value, temperature, and molecular weight o f the inner material (Takagishi,
1994; Antipov, 2002; Kim, 2004; Yang, 2005; Pargaonkar, 2005; Windhab, 2005; Tong,
2006). To determine how these factors can influence the transport phenomena, it is
necessary to develop a theoretical model. The determination o f the mass transfer
coefficient value yields clear insight into the characterization o f microcapsules with semipermeable membranes (Lewinska, 2002; Rosinski, 2005). Due to the semipermeability o f
the capsule wall, Tong (2006) created a Donnan equilibrium between the inner solution
within the capsules and the bulk solution. Kwok et al. (1991) developed a general
diffusion model for alginate-polylysine (PLL) microcapsules which can describe mass
transport phenomena and membrane diffusivities. The apparent size o f the impermeable
gel core and the capsule membrane permeability were used to describe the results.
Factors that can affect the results are the size o f the diffusing protein and the alginatePLL reaction time. These microcapsules can be used in cell culture engineering and cell
transplantation by affecting cell viability. Manca et al. (2003) modeled the release
process within the human body. In that model, they showed how polymer coating can
affect the transport phenomena.

11
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CHAPTER 3

DROPLET GENERATION MODEL

3.1 Introduction
For application purposes, it is desirable to produce alginate microspheres in the
range o f 40-50 pm in diameter. Such capsules have been produced in Dr. Palmer’s
laboratory at Louisiana Tech University using alginate and vegetable oil as the
immiscible phase. Before the wide use o f microchannels, microparticles were generated
through a microporous membrane and jet pinch-off. The microchannel technique
involves the use o f a T-shaped channel micro fluidic device with a bifurcating junction
(Figure 3.1) which allows for the mixing o f the two immiscible phases, alginate and
vegetable oil.

Figure 3.1. Enlarged T-shaped channel

12
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The alginate microparticles are produced due to the interfacial tension (or force)
generated between the two immiscible phases. When alginate molecules at the interface
are subjected to this interfacial force, they rearrange themselves in order to reduce this
exerted force. This rearrangement is in the form o f a spherical configuration since this
reduces the surface area and produces the least strain on the system.

3.2 Experimental Procedure
The experimental setup is shown in Figure 3.2. The critical components are
labeled in the diagram.

Vegetable
oil pump
Vegetable
oil source

^Droplet
generator
Alginate
pump

lginate
source

T shaped
channel

Figure 3.2. Experimental setup
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3.2.1 Preparation of the Two Phases
Calcium chloride solution: 10% wt o f calcium chloride is made by adding 50 g o f
calcium chloride into 500 g o f water.
Alginate solution: 2% wt alginate solution is made by adding 4 mg o f FITC
dextran and 0.6 g o f sodium alginate into 30 g o f water.
3.2.2 Process
Alginate and calcium chloride solutions are inputed into the system at the same
time. After the flows are stabilized, the alginate particles sheared by the calcium chloride
flow are sent into the CSTR containing the calcium chloride solution which is under
constant stirring (over head stirrer). Alginate spheres tend to coagulate at the inter phase
surfactants. In order to prevent coagulation, Tween 80 (2%v/v) and Span 80 (1.5%v/v)
are added to tlje dispersed and the continuous phase.

3.3 Mathematical Model
Droplets are generated by the imbalance between the interfacial tension and the
Laplace pressure. Alginate molecules arrange themselves into microspheres in order to
reduce the tension by reducing their interfacial area. A spherical configuration minimizes
the stain on the system.
FLUENT, a computational fluid dynamics (CFD) software, can be used to
simulate complex engineering problems. We can use FLUENT to model droplet or
microcapsule generation. The model can be verified by comparing predicted values to
experimental results. A model that can accurately simulate the process o f droplet
generation would be useful for planning and design o f experiments and for reducing
experimental time and cost.
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The model chosen in FLUENT for droplet generation is the volume o f fluid
(VOF) model. The VOF model can simulate the behavior o f two immiscible fluids by
solving the momentum equation in each cell and tracking the volume fraction o f each
fluid throughout the domain. The volume fraction o f the phase in the computational cell
is introduced as a variable for each phase in the model. The volume fractions o f all
phases sum to unity in each cell. The whole domain is meshed into a large number o f
cells. For two phases, let a q stand for the qXh fluid volume fraction (q = 1,2) in a cell. It
is seen that
1.

a = 0 implies that the cell is empty o f the qih. fluid.

2.

a q = 1 implies that the cell is full o f the qXh. fluid.

3.

0 < a q< \ implies that the cell contains both the qXh fluid and the other
fluid. A cell that conatins both fluids is at the interface.

The solution o f the continuity equation, Equation 3.1, for the volume fraction is
used for the tracking o f the interfaces between the two phases.

da

—+ v- V a

= 0

dt

(3.1)

In Equation 3.1, a q stands for the ^th fluid’s volume fraction in the cell,
v stands for velocity vector o f the fluid in the cell, and
t stands for time.

All phases in each cell sum to unity,
n

(3.2)
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Thus, the density and viscosity in a given cell can be evaluated as weighted means
o f the densities and viscosities o f the individual phases. The weights are the volume
fraction o f the phases. For instance, one can use the following equations to represent the
density and viscosity in each cell:
P =

»

(3-3)

where p stands for the density in the cell,
a q stands for the qXh fluid’s volume fraction, and
p q stands for the density o f the q\h fluid.

Also,

P^Yua<iPq

(3-4)

where p stands for the viscosity in the cell,
a q stands for the ^th fluid’s volume fraction, and
p q stands for the viscosity o f the qih. fluid.

The properties p and p depend on the volume fractions o f all phases. Therefore,
the momentum equation in a cell, in which p and //a re included, is dependent on the
volume fractions o f all phases. The VOF model simulates the process by solving a set o f
momentum equations over cells and tracking the volume fraction o f all the phases
throughout the domain. As such, p and p are the connection between the momentum
equation and the volume fractions o f the two phases.
The 2-D continuity equation used in this model is
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where p is the density,

v is the velocity vector for the two fluids.
Momentum is a vector quantity. It is based on Newton’s second law o f motion.
This is expressed as
(3.6)

P = mv

Where P stands for momentum,
v stands for velocity o f the fluid in the cell, and
m stands for mass o f the fluid in the cell

Dividing the left and right hand sides o f Equation 3.6 by time t, one obtains the
following equation:
(output - input + accumulation) x rate o f momentum=

,

(3.7)

where F is the force.
The momentum equation for every cell is:

— ( p v ) + V - ( p v v) = - V/>+V-[/i(Vv+Vv ) ] + p g + F ,
dt
Where t is time,
-»

v is the velocity o f the fluid in the cell,
p is the density in the cell,
p stands for the pressure exerted on the fluid in the cell,
p stands for the viscosity in the cell,
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g is the gravitational force exerted on the fluid in the cell, and
—»

F is the friction force exerted on the fluid in the cell.

The first expression on the left hand side o f Equation 3.8 represents the increase
in momentum. The second expression on the left hand side o f Equation 3.8 represents
momentum input by convection. The first expression on the right hand side o f Equation
3.8 represents the pressure force. The second expression on the right hand side o f
Equation 3.8 represents momentum input by viscous forces. The third expression on the
right hand side o f Equation 3.8 represents gravitational force. The fourth expression on
the right hand side o f Equation 3.8 represents friction force.
The boundary conditions and initial conditions for the momentum equation are:
Boundary conditions:
Alginate input and vegetable oil input are defined as velocity inlet boundaries
describing flow entering the physical domain o f the model. FLUENT uses the velocity
inlets boundary conditions to compute the mass flow into the domain through the inlets
and to compute the fluxes o f momentum, energy, and species through the inlets. The
mass flow rate entering a fluid cell adjacent to a velocity inlet boundary is computed as
m = ^ p v-d A,

where m stands for the mass flux,
p stands for the density in the cell,
—>

v stands for velocity o f the fluid in the cell, and
A stands for the area.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(3.9)

19

The oil/alginate interface boundary is computed as
mi - J p v - d A t - p Q i

(3.10)

where w, stands for the mass flux going through the interface area
—►

Ai stands for the interface area

Q, volume o f fluid
The output boundary is defined as the outlet pressure. FLUENT uses condition
pressure as the static pressure o f the fluid at the outlet plane, and all other conditions are
extrapolated from the interior o f the domain.
The boundary condition at the wall is a fixed heat flux o f zero. Walls are
stationary and shear condition at the wall is no slip.
Initial conditions:
va = Vj, at the alginate input interface
va - 0 , otherwise
va = v2, at the vegetable oil input interface

vc = 0 , otherwise,
where va stands for the velocity o f alginate,
v0 stands for the velocity o f vegetable oil, and
v, and v2 stand for the constants.

It is seen that the momentum equation Equation 3.8 and volume fraction equation
Equation 3.1 are coupled equations. The velocity in Equation 3.1 is obtained from the
solution o f Equation 3.8. Also, the solution to the momentum equation depends on p and
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//w hich in turn depend on the knowledge o f the volume fraction from Equation 3.1.
Hence, the VOF model simulates the process through a simultaneous solution o f Eqs. 3.8
and 3.1.

3.4 Simulation
FLUENT, as a powerful CFD software, is used in this research to simulate the
droplet generation process. The volume o f fluid (VOF) model was chosen because it can
model two immiscible fluids by solving a set o f momentum equations and tracking the
volume fraction o f each o f the fluids throughout the domain.
The simulation process includes the following steps:
•

Designing the geometry o f the channel

•

Setting up the model

•

Running the model

•

Evaluating the results

3.4.1 Designing the Geometry
of the Channel
Gambit 2.1 as the preprocessor for FLUENT is used to design the geometry o f
the channel. There are three main steps in the design o f the geometry.
•

Draw a 2-dimensional area to represent the channel. To draw the area, one
needs to locate all the points by specifying x and y coordinates, join the
points to obtain the sides (boundaries), and then connect all the sides
together to get the 2-D area (Figure 3.3).
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Gx

Figure 3.3. Two-dimensional area o f the channel

•

Mesh the 2-dimensional area (Figure 3.4), see the enlarged graph (Figure
3.5). FLUENT operates on this area using the finite volume method.
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Figure 3.4. Two-D area mesh

-

*= -

*•

- Hi -

Figure 3.5. Enlarged 2-D mesh

•

Set the type o f boundaries. As is shown in Figure 3.6, a velocity inlet is set
for the alginate input, two velocity inlets are set for vegetable oil input,

and a pressure outlet is set for the output. The other boundaries are wall
boundaries.
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Figure 3.6. Boundary types o f the channel sides

The design o f the channel geometry can be saved as a mesh file which
includes the channel geometry and the boundary type information.
3.4.2 Setting up the Model
A mesh file is created by Gambit with all the information about channel
geometry and boundary conditions. FLUENT will take the file over from Gambit to set
up the model according to the following steps:
•

Import the mesh file.
The mesh file created by Gambit is imported into FLUENT. The mesh file

provides the geometry information. The next step is to specify the unit
according to the experimental equipment shown in Figure 3.7.
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Figure 3.7. Scale grid

•

Choose the solver and model.
The segregated solver is chosen. An implicit unsteady first order

formulation is used in this solver. PRESTO! and PISO schemes are chosen for
pressure and pressure-velocity coupling. The momentum scheme is the first
order upwind. In order to specify the VOF model, one needs to set up the
materials and phases.
•

Materials and phases.
The two fluids, alginate and vegetable oil, are created by specifying

density

the

and viscosity properties o f the fluids. Vegetable oil is set to be the

primary phase and alginate the secondary phase. Interfacial tension between
the primary phase and the secondary phase is set to be 1 because the two
phases are immiscible.
•

Boundary conditions:
The boundary conditions need to be specified for the VOF model. Walls

are stationary and shear condition is no slip as default. Output is the pressure
outlet satisfying PRESTO! and PISO schemes. The vegetable oil velocity inlet
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is the input o f the primary phase. So the phase for this boundary is the primary
phase vegetable oil and the input velocity o f this phase is entered here. The
alginate velocity inlet is the input o f the secondary phase. So the phase for this
boundary has to be the secondary phase alginate and the input velocity o f this
phase is entered here.
3.4.3 Running the Model
The above steps are all that is needed to set up the VOF model. To run this
model, the setting of the initial conditions and iteration is required.
•

Initial conditions:
The initial velocity for all the cells is zero except for the boundaries o f

alginate input and vegetable oil input. The initial velocity o f alginate at the
alginate input boundary is entered here and the direction is along the x axis.
The initial velocity o f vegetable oil at the vegetable oil input boundary is
entered and the direction is along the y axis.
•

Iteration:
In this step, the time step and the number o f sub-steps are specified. The

time step is the maximum interval which can guarantee convergence and
shorten the simulation time.
3.4.4 Parallel Computing on
a Linux Cluster
FLUENT can work efficiently on a PC for small problems. For big problems,
like the droplet simulation in this paper, we used parallel computing on a cluster to
reduce calculation time. Cluster computing was considerably faster than the PC. Parallel
computing is widely used in the scientific computing and engineering analysis
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communities. The idea is to connect several computers together to solve a single problem
using their collective power. A multi-processor FLUENT job is launched from a “host
node.” A graphical user interface (GUI) is run on the host node. Using the Putty (a
telnet/SSH client) and Cygwin (Linux-like environment for Windows), FLUENT on the
cluster can be run on any PC as a terminal.
Figure 3.8 shows how the idea works in FLUENT, the communication
between all nodes represents passing messages.

H m ! N rn l?

H.UFNI t . f u r u h
R U F N ' f CUf
C ontfH rtr- N o d i1 0

Figure 3.8. Running FLUENT on a cluster
It is seen from Figure 3.8 that all the nodes can run in parallel. This can reduce
the turn-around time in computation. As is shown in Figure 3.9, computation speed as a
function o f project size increases with an increase in the number o f processors in the
cluster.
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No of Processors

Figure 3.9. Parallel computing performances o f different number o f processors

Figure 3.9 represents three size groups. The droplet simulation project has
300,007 cells, which belongs to the larger size group. As such, performance was
dramatically improved by parallel computing. Fourteen processors were used in the
simulation because o f the limitation o f the license Louisiana Tech University purchased.
3.4.5 Evaluating the Results
The volume fraction distribution o f the secondary phase (alginate) is captured
in graphical mode every time step. All the graphs are connected into a video to show how
alginate is sheared by the vegetable oil flow. The droplet size and its variance can be used
to describe the results. In Chapter 4, comparison o f the simulation results and
experimental results is studied in detail.
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CHAPTER 4

RESULTS AND DISCUSSION OF
DROPLET GENERATION

4.1 Introduction
This chapter deals with the simulation o f a two phase flow process in a 100
micron width channel for the generation o f droplets. The geometry in Figure 3.3 is used
with proper boundary conditions. Comparisons between the theoretical results from
simulation and experimental results are presented.

4.2 Simulation Design
A factorial experiment at two levels with a center point (Table 4.1) was used in
order to obtain an optimum factor combination that gave the desired particle size with
minimum variance. The velocity o f the vegetable oil and the velocity ratio o f vegetable
oil to alginate were considered as the two quantitative continuous factors. The idea used
is based on response surface methodology. It involves collecting observations at each
location on a grid o f treatment combinations spanning the entire simulation region, and
then estimating the response surface in the vicinity o f the optimum response. Based on

the responses obtained from the first design in Table 4.1, an optimum was selected and a
second factorial experiment (Table 4.2) was run in the vicinity o f this optimum.

28
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Table 4.1. Simulation runs for different factor combinations

Model
Exp100-1
Ex p100-2
Exp100-3
Exp100-4
Exp100-5

Vegetable
Oil
Coded
-1
-1
1
1
0

Uncoded
0.05
0.05
0.2
0.2
0.125

Ratio
Coded
-1
1
-1
1
0

Uncoded
5
25
5
25
15

Table 4.2. Simulation runs for different factor combinations in the vicinity o f an optimum
droplet size and variance
Vegetable
Oil
Model
Exp100-11
Exp100-12
Exp100-13
Exp100-14
Exp100-15

Coded
-1
-1
1
1
0

Ratio
Uncoded
0.08
0.08
0.12
0.12
0.1

Coded
-1
1
-1
1
0

Uncoded
8
12
8
12
10

4.3 Simulation Results
In running the simulation, the alginate volume fraction contours, as shown in
Figure 4.1 were used to represent the alginate phase distribution which ranges from 1
(red color) to 0 (blue color). For the runs in Table 4.1, Exp 100-1 and Exp 100-2 did not
generate any droplets (Figures. 4.2 and 4.3a). This was attributed to the low velocity o f
the vegetable oil. In Exp 100-3, alginate was distributed as a stream because o f the low
ratio (Figure 4.3b). Particles or droplets were generated in the case o f the two runs,
Exp 100-4 and Exp 100-5 (Figure 4.4 a, b). However, the particle size was too small in
both o f these runs, but in Exp 100-5, the particle size was much larger than in the case o f
Exp 100-4. As a result, the experimental runs in Table 4.2 were designed in a new region
with center point at 0.1 m/s for the vegetable oil velocity and 10 for the ratio.
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Figure 4.1. Alginate volume fraction
contours

Figure 4.2. Exp 100-1 alginate volume
fraction contours

Figure 4.3. (a) Exp 100-2 and (b) Exp 100-3 alginate volume fraction contours
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Figure 4.4. (a) Expl00-4 and (b) ExplOO-5 alginate volume fraction contours

In ExplOO-11 and Expl00-13 o f Table 4.2, alginate was distributed as a stream
because o f the low ratio (Figures 4.5a, 4.6a). Particles were produced in the cases o f
Expl00-12 (Figure 4.5b), Expl00-14 (Figure 4.6b), and Expl00-15 (Figure 4.7). The
Exp 100-15 run gave the largest particle size and the largest variance. The means and
standard deviations for the short and long droplet diameters are presented in Table 4.3.
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Figure 4.5. (a) ExplOO-11 and (b) Expl00-12 alginate volume fraction contours

Figure 4.6. (a) Expl00-13 and (b) Expl00-14 alginate volume fraction contours
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Figure 4.7. Exp 100-15 alginate volume fraction contours

Table 4.3. Average and standard deviation for short and long particle droplet diameters
for the different experimental runs
Standard
deviation
o f short
diameter

Average
long
particle
diameter
(pm)

Standard
deviation o f
long
diameter

21.7
No D.F.

8.1

25.1

8.6

22.9
22.7

7.2
11.3

24.8
26.9

8.5
17.5

Algina
te flow
rate
(m/s)

Oil
flow
(m/s)

Ratio

Average
short
particle
diameter
(pm)

0.01

0.08

8

No D.F.

Exp100-12

0.0067

0.08

12

Exp100-13

0.015

0.12

8

Exp100-14

0.01
0.01

0.12

12

0.1

10

Case #

Exp100-11

Exp100-15
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4.4 Results
As it is shown in Table 4.3, the coefficient o f variation (standard deviation/mean)
o f the short diameter ranges from 0.314 to 0.498 and that o f the long diameter ranges
from 0.342 to 0.65. Expl00-15 has the largest coefficients o f variation (0.498 for the
short diameter and 0.65 for the long diameter). Considering the mean and coefficient o f
variation for droplet size, it would seem that the factor combination in Exp 100-14 gives a
relatively large mean diameter and small coefficient o f variation and is to be preferred to
the other experimental runs.
For all the simulation in this study, the following properties for oil and alginate
were used.
Olive oil:

Density 930 kg/m3
Viscosity 0.03 kg/m-s

Alginate:

Density 1012 kg/m3
Viscosity 0.21372 kg/m-s

In order to determine if changing the properties would decrease the variance from
that observed in Table 4.3, we changed, for simulation purpose, the properties o f oil and
alginate as follows:
Olive oil:

Density 918 kg/m3
Viscosity 0.084 kg/m-s

Alginate:

Density 998.2 kg/m3
Viscosity 0.001003 kg/m-s

The biggest change was in the viscosity o f alginate which made it closer to water.
Run Exp 100-16 represented the low viscosity o f alginate. Comparisons o f the mean and
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standard deviation for Exp 100-15 and Exp 100-16 show that the means are almost the
same, but the variance for the low viscosity (Exp 100-16 run) was much smaller than that
for Exp 100-15. The variance changed from 11.3 to 7.97 for the short diameter and from
17.5 to 9.18 for the long diameter. It should be noted that since density and viscosity for
oil and alginate are what they are, changing the viscosity or density for simulation
purposes would imply that in practice one should use other materials for generating a
droplet size with low variance or coefficient o f variation.

Figure 4.8. (a) Expl00-15 and (b) Expl00-16 alginate volume fraction contours.

4.5 Future Work
In this research, the velocity and ratio were considered as two factors. One can
obtain the desired particle size by adjusting these two factors affecting the size o f
generated microcapsules. Also, it was observed that the properties o f the two immiscible
phases can influence the variance. In all the above simulations, the channel was straight
with the width fixed at 100 micrometers. In future work, it would be o f interest to
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determine if channel width and or geometry will have any effect on droplet size and
variance.
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CHAPTER 5

MODELING OF TRANSPORT PHENOMENA

5.1 Introduction
“The main focus in the area o f emulsion technology is to improve stability and
control the release o f active matter in double emulsions” (Lyon, 2002). Because o f the
permeability property o f a microcapsule’s wall, microencapsulation is an important
technique used to protect the inner materials from the outer materials or to control the
release o f the encapsulated inner materials. In so many applications o f microcapsules, a
critical question is how to control the transport phenomena. To develop a theoretical
model, it is necessary to determine how different factors can influence the transport
phenomena. These factors include type and thickness o f the wall, loading time o f the
inner material, pH value, temperature, and molecular weight o f the inner material
(Takagishi, 1994; Antipov, 2002; Kim, 2004; Yang, 2005; Pargaonkar, 2005; Windhab,
2005; Tong, 2006).
Due to the semipermeability o f the capsule wall, Tong (2006) created a Donnan
equilibrium between the inner solution within the capsules and the bulk solution. Kwok et
al. (1991) developed a general diffusion model for alginate-polylysine (PLL)
microcapsules which can describe mass transport phenomena and membrane diffusivities.

37
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In this chapter, the finite difference method is applied to model the transport
phenomena o f microcapsules.

5.2 Experimental Procedure
Layer-by-layer assembly o f oppositely charged polyelectrolyte onto removable
colloidal particle surfaces has been used by many groups because o f its potential
application (Radtchenko, 2000; Antipov, 2002; Tong, 2006). At the Institute for
Micromanufacturing (IFM), Louisiana Tech University, poly (styrene sulfonate) (PSS),
poly (vinylsulfat) (PVS), poly (allylamine) (PAH) and poly (diallyldimethylammonium
chloride) (PDDA) are the four polyelectrolytes used in layer-by-layer encapsulation o f
microsphere colloidal core material (melamine formal dehyde (MF)) to obtain multilayer
microcapsules.
5.2.1 Preparation of the Materials
Polyelectrolyte solutions: 1 mg/ml PSS or PAH with 20 mM o f Tris-buffer and
0.5 M NaCl.
Solvent solution: 0.1 MHCI.
Dextran solution: 0.15 mg/ml o f 4000MW FITC-dextran or 0.14 mg/ml o f 77,000
MW FITC-dextran.
Core particles: melamine formaldehyde (MF) colloidal core particles o f 5.3 pm in
diameter.
5.2.2 Process
•

Layer deposition: Polyelectrolyte PSS or PAH layer is deposited onto the
MF core material by incubation for 15 min in the polyelectrolyte solution
sequentially. After depositing every layer, the particles are washed three
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times in a 121 mM Tris-buffer solution and centrifuged at 6000 rpm for 5
min to remove the wash.
•

Dissolving the melamine formaldehyde core: A 0.1 MHCI solution is used
to dissolve the core after depositing the desired layers. Centrifugation
during the wash after core removal is performed at 3000 rpm for 8 min to
minimize damage to the resultant shells.

•

Loading dextran: 0.15 mg/ml o f 4000MW FITC-dextran or 0.14 mg/ml of
77,000 MW FITC-dextran is loaded into the hollow microcapsules from
the above procedure for 12, 36, and 60 h at a pH o f 7. Seven washes are
performed with 20 mM Tris-buffer to remove loosely associated FITC
labeled dextran.

•

Transport phenomena: The prepared FITC labeled dextran microcapsules
are immersed into the mother-liquor (or bulk) to study the transport
phenomena. A Quanta Master TM Model QM-2000-4 excitation/emission
spectrofluorometer is used to quantify the concentration o f FITC labeled
dextran in the mother-liquor o f the sample.

5.3 Governing Equations
=

dt

(51)

r 2 dr

dr

where C stands for the concentration,
t stands for the loading time,
Di stands for the ith diffusion coefficient, in the core (i= l), wall membrane
(i=2), and bulk liquid (i=3),
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r stands for the radial distance from the center.
In

this model, we assume that the core diffusion coefficient ( Z>, ) and the

membrane diffusion coefficient ( D 2) and outside medium diffusion coefficient ( Z>3) are
constant and not a function o f distance or time.
In all experiments, dextran was first allowed to diffuse into the microcapsules for
a certain length o f time (loading period). After the loading was complete, the
microcapsules were immersed in a water medium where dextran was released to the
outside. Both loading and release are transfer phenomena and can be simulated by the
diffusion model in Equation 5.1 with different initial and boundary conditions.
Loading Initial Conditions:

where

C(r,0) = 0 , 0 < r < i?2

(5.2.1)

C(r,0) = Cout,R2 < r < R 3,

(5.2.2)

R2 stands for the radius o f the microcapsule.
R3stands for the radius o f the total area, microcapsule and outside

medium
C (r,0) stands for the concentration o f dextran at position r at time 0.
Cout stands for the concentration o f dextran in the outside medium and was

equal to 0.14 mg/ml.
Initial conditions are the conditions at t = 0. So at time 0, the dextran
concentrations in the core and in the membrane were 0. In the outside medium, the
concentration was 0.14.
Loading Boundary Conditions:
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(5.3.1)
dr

(5.3.2)

C, = C2, r = R}

(5.3.3)

(5.3.4)

A
C2 = C3,r - R2

(5.3.5)

(5.3.6)

where C, stands for the dextran concentration in the core.
C2 stands for the dextran concentration in the membrane.

C3 stands for the dextran concentration in the outside medium.
D x, D 2, and D 3are the diffusion coefficients o f core material, membrane

and liquid bulk (outside medium).
Release Initial Conditions
C(r, 0) = C ( r ,t ) , 0 < r < R2
C(r, 0) = 0 ,R2 < r < R 3,

(5.4.1)
(5.4.2)

where R2 stands for the radius o f the microcapsule.
C(r, 0) stands for the concentration o f dextran at position r at time 0.
C(r,t) stands for the concentration o f dextran at position r at time t,

where t is the loading time.
Initial conditions are the conditions at time 0. As is known from the experimental
conditions, the microcapsules were loaded with dextran for a certain time, t. So the initial
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condition for the release process is C ( r , t ) , which is the dextran concentration at position r
at time t. C(r,t) is obtained from the diffusion model during loading time.
Release Boundary Conditions:
(5.5.1)

(5.5.2)
C, - C2, r = R

(5.5.3)
(5.5.4)

C2 = C3,r = R

(5.5.5)

(5.5.6)

where Cxstands for the dextran concentration in the core.
C2 stands for the dextran concentration in the membrane.

C3 stands for the dextran concentration in the bulk.
D x, D 2, and D 3are the diffusion coefficients o f core material, membrane

and bulk.

5.4 Calculation of Transport Phenomena
Based on Governing Equations
5.4.1 Fractional CrankNicholson Method
More and more scientific and engineering problems involve fractional calculus.
Recently, Metzler et al. (1999), Barkai et al. (2000), Metzler et al. (2000) proposed a
fractional Fokker-Planck equation to describe subdiffusive anomalous transport in the
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presence o f an external field. This equation becomes the fractional partial differential
equation for the force-free case (Balakrishnan, 1985; Scalas et al., 2004; Metzler et al.,
2000; Schneider et al., 1988).
The Crank-Nicholson method is applied for solving the governing spherical finite
difference equations. This method uses central differences rather than the forward
difference o f the Euler method or the backward difference o f the backward Euler. The
Crank-Nicholson method is also called the 5-point method. Every point is related to the
adjacent five points as shown in Figure 5.1.

Ci}
Q

r

y+i

C,

C:7+1,y+1

Figure 5.1. Five-point method

Cf . represents the dextran concentration at position i at time j. In the CrankNicholson method, the calculation o f a value at a given point depends on the five adjacent
points.
Crank-Nicholson method:

(5.6.1)
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where 0 is the weight factor,
If 0 = 1, Equation 5.6.1 gives rise to the fractional explicit method (Yuste et al.,
2003; Yuste et al., 2004).
If 0 is not equal to 1, the method is implicit.
If 0= 0, the method is fully implicit.
If 0=1/2, Equation 5.6.1 is the fractional Crank-Nicholson method.
For 0=1/2 and ji = ~ —

, Equation 5.6.1 is re-written as follows:

y_i
(5.6.2)

5.4.2 Stability Analysis
It is known that the exact solution o f the differential equation can be expressed as
a Fourier series. The Fourier mode o f the fractional Crank-Nicholson method is as
follows:
n

where X -

ik (j A x)

l- 2 Z ) s in 2—A:Ax
2
71
l + 2Z)sin —kAx
2

(5.7.1)

(5.7.2)

X is called the amplification factor for the mode. This mode will be stable as long

as (X)n is bounded as n —> <x>. In other words, 0 < X < -1 is the requirement if the mode is
to be stable. The diffusion coefficient D is larger than 0. As a result, X cannot be larger
than 1. Since this is a three-region diffusion model, D has different values for different
regions. D mem stands for the diffusion coefficient o f the membrane. D core and D out stand
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for the diffusion coefficients in the core and bulk or outside solution.

The diffusion

coefficients in the core and bulk can be large enough to cause A to become negative,
which leads to an unstable mode. In order to attain stability, the fully implicit scheme
was used in the core and bulk regions.
5.4.3 Thomas Algorithm
Concentrations C at different positions at different times are the variables in
Equation 5.6.2.

C,-_, ■, C,- ■, and CM j on the right hand side o f the equation are the

concentrations at positions i-1, i, and i+1 at the previous time step j. We can consider
these three variables as known. CM /+1, C, j+i , and CM j+l on the right hand o f the
equation are the concentrations at positions i-1, i, and i+1 at the new time step j+ l,
which are considered as unknown. Equation 5.6.2 can be simplified as follows:
—h,CM, +1 + fl-C- -+1 —c-C-, ■, = d i ,i = l,

c

'- 'o J + l

=c

'- 'l J + l »

c

n-1 J + l

,n

=c

(5.8)

nJ+ l

Here, ai,bi,ci are the coefficients corresponding to Equation 5.6.2 and d i is a term
related to C(._, .,Cf -.C^, ■. In other words, when the new time step i+1 is calculated,
d t can be considered as known from the previous time step. For every three adjacent

points, we can get an equation like Equation 5.8. So for all the n+1 points in the domain,
we can get n-1 schemes like the above one. All the schemes can be written in matrix form
as follows:
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(N

0
1

(N

1

r

~b;

c

ax

-K-x

an-i

c

cn_x

~ b n an - c n_ _

'

U+i

d2

2,7 + 1

1,7 +1

dt

-

d.-i

n-1,7 + 1
c

n,j+l

dx~

_

dn

(5.9)
The usual approach to solve tridiagonal linear systems is the Thomas algorithm
(William, 1941). The forward Thomas algorithm is shown as follows:
•

When / = 1, Equation 5.8 is applied to give
—^i^oj+i + a\C\,j+\ ~ c\^2,j+\ = d\

(5.10.1)

At the boundary condition, Coj+x = C, /+1, so the terms are combined to give
Equation 5.10.2.
(«1 “ W j + i ~ ciC2,j+i=dx

(5.10.2)

Both sides are divided b y ^ -ft,) to give
d\

C

(5.10.3)

lT '("2J+1 ~ f + e\C2Jj +1
Cl,7+1 ~ ax - b x + ---ax- bx
•

When / = 2, Equation 5.8 becomes
~ ^ 2 ^ 1 , j+ l

^ a 2 ^ 2 ,j+ l

(5.10.4)

~ C2 ^ 3 J + l = d 2

Equation 5.10.4 is simplified by applying Equation 5.10.3 to obtain Equation
5.10.5.
r

2,j+ l

2 + Kfi .
2
r
i
z.
a2 - b2ex a2 —b2ex

3./+1

- f + e C
J2

2

3, j + l
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•

When i= l,

, n, the general equation is
(5.10.6)

(5.10.7)

(5.10.8)

Using the same approach, the backward Thomas algorithm can be obtained. The
general equation is as follows:
(5.10.9)

(5.10.10)

(5.10.11)

The algorithm introduced above is easy to use in a SIMD (Single Instruction,
Multiple Data). A new parallel method was introduced by Dai (2000) for time saving.
The problem can be decomposed into a number o f independent sub-problems and all the
sub-problems can be preceded independently. Later on, the solutions o f all the
independent sub-problems can be combined to obtain the solution o f the original
problem. The parallel application for this research is shown as follows:
•

0 < r < Rx, the core material. The forward Thomas algorithm is applied as
in Equation 5.10.6. At the inside o f the membrane, the concentrations
satisfy the following conditions.
(5.11.1)
(5.11.2)
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Equations 5.11.1 and 5.11.2 are combined to eliminate the variableCR

1J+1.

This gives

c ,,, =

(| >- + 1 1e„ , + 1) C

, , f,,

(

5.11.3)

the liquid bulk. The backward Thomas algorithm is applied as in
Equation 5.10.9. At the outside o f the membrane, the concentrations need
to satisfy the following conditions.

Cr2+\j+i = fl>n2+i + ebR^+lCR^j +l
A (CR2j+, - C w

l ) = D2{CR2+l- C Ri)

(5.11.4)
(5.11.5)

Equations 5.11.4 and 5.11.5 are combined to obtain Equation 5.11.6.

C«. - u„ =
.

- f - A ...

(5.11.6)

R , < r < R2 , the membrane material. The following equations are applied
in that region.

Of,+1J+1

=

f R,+l~^eRl+l^'Rl,j+i ^ Sr1+1^-'R2J+1

C r 2 - \ J + \ — f i , R 2- i T e b R2 - \ ^ R 2 ,j+ \ T S ^ >R1 - S - ' f l j . y + l >

where

,eXi = 0
a R,+ 1

(5.11.7)

(5*1 1-^)

(5.11.9)

^R i+ i e R,

j =^,+i+ViA j =0

(5.11.10)

aR,+l- b Ri+leRi

g*,+1=

bR'+~*'h

,g ,,= 1

a R l+ l ~ e R t b R l+ l
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2 \-. =

bR" X ~
f l .S2 - l

~

A 2-, =

dR
2

, +

>««, = 0

(5-1L12>

/&„ ~
' 2 >A , = 0

(5.11.13)

C R 2- \ e R2

Cb

,

2

f l R2 - l

C R1 - \ e ^) R1

a fl2 -1

6 ^ fi2 C« 2 -1

gb „ . , =

,* 6 „ ,= 1

(5.11.14)

Equations 5.11.3, 5.11.6, 5.11.7 and 5.11.8 can be used to solve for
C

C
*>-7+l and fl2 j,+1, which are used to calculate all the concentrations at any position at the

new time step.
The parallel procedure is as follows:
•

Calculate ei and f ni = 0,....,RX, and calculate Equation 5.11.3.

C
=(— + —
e*1-1 +1)C
'- 'R ,+1,7+1
£)
'
* iJ + l

•

Calculate

+1,

+1and

^ R , +1,7+1

£)

+1 to obtain Equation 5.11.7.

f

e R , + ^ R u j+ \

& R i + \ C r 2 j +\

Calculate e b R x, f b R^_xand gbRi_x to obtain Equation 5.11.8.

C r 2 -1,7+1 = f l JR 2 - 1 + e ^ R 2- \ ^ R 2 ,j + \ + S ^ >R 2 - \ ^ - ' R l , j + l

Calculate eb{ and f b i , i = R2,

C r 2 -1,7+1 ~ ( p

Solve for

C

N , and calculate Equation 5.11.6.

e ^ R 2+ \ + ^ ) ^ R 2 J + \

p

f l >R 1 +l

C
R"J+] and RlJ+' using the above four equations.
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•

Calculate all concentrations at any position at the new time step using Eqs.
5.11.1 and 5.11.4.

5.4.4 Inverse Problem
5.4.4.1 Introduction. Inverse analyses have many applications in various branches o f
science and engineering such as that o f chemical engineering, geophysics and statistics.
Difficulties arise with the implementation o f an inverse analysis. The main difficulty is
that the inverse solution may not be unique, because it is very sensitive to the changes in
input data resulting from measurement and modeling errors. Inverse problems cannot
satisfy the general requirement o f existence, uniqueness, and stability under small
changes in the data, so they belong to the ill-posed problems mathematically.
Inverse problems have attracted the interests o f many scientists and engineers.
Many analytic and numerical approaches have applied to inverse problems. The Duhamel
method was utilized by Stoltz (2004) to develop an analytic solution for a linear inverse
heat conduction problem. As one o f the earliest investigators, Stoltz offered us a good
insight into the problem. Stolz’s solution, however, was found to be unstable for small
time steps. In the nonlinear case, the finite difference method (FDM) and the finite
element method (FEM) were used to solve the inverse heat conduction problems (IHCP).
5.4.4.2 Inverse Solution
and Least Squares. In this research, a diffusion formulation and solution is
presented to simultaneously estimate the unknown diffusion coefficients. Because the
inverse solution can minimize the least squares norm, the existence o f the inverse
solution is guaranteed.

S { h = f J[Yi - T i( p * ) f , j = 1,2
1=1
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where Yt stands for the measured concentration,
A

A

T ( P j ) stands for the estimated concentration obtained from the solution

o f the direct problem by using the estimated values o f the unknown parameters,
A

Pj

stands

for the

elements

o f the unknown parameter vector

A

p - {D, , D 2} t , and Q stands for the total number o f the measurements.

The sum o f squares can be minimized by differentiating it with respect to each o f
A

the unknown parameters p

(j= l, 2) and then setting the resulting expression equal to

zero.
ac

n

p<rp

A A

= 2 S ( ^ LXr.-(p)-J;) = o,; = i,2
8Pj

(5.12.2)

Spj

Equation 5.13.2 is written in matrix form as
(5.12.3)

^ = 2 X t ( T - Y ) = 0,
dp
A

where T =

dTx

dp,

dp2

dT2

dT2

dpi

dp2

dfa

dTn

dp,

dp2

T

~Ti'
TiI

dT]

,Y =

y1
2

Pi
A

Pi

, and X = — zr
A

V

d T

A 1

dp

. TO-

X is the sensitivity coefficient matrix with respect to p.
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5.4.4.3 Levenberg-Margguardt
Method. We can see that the system o f equations in Equation 5.12.3 is nonlinear,
so an iterative technique is required here to get the solution. The modified LevenbergMarquardt (LM) algorithm, a combination o f the Newton method and the steepest
descent method, can be used to solve the nonlinear least squares equations by iteration
(Ozisik, 1993).

A i+ 1

p

A

4

= p + ( J TJ + p ki y ' J T( Y - T ) , k = 1,2,3,....

(5.12.4)

A

where p = {DVD 2}T = estimated parameter vector,
Y stands for the measured concentration,
p k stands for damping parameters, and
J = X = the sensitivity coefficient matrix with respect to p.

The speed o f the Levenberg-Marquardt (LM) iterative least-squares method for
the nonlinear problem depends upon the choice o f the damping parameters. To solve
difficult problems efficiently, LM requires additive damping with small damping
increments and large damping decrements, Lampton (1997).
5.4.4.4 The Solution Algorithm
with LM. The following is the solution algorithm with the LM method.
1.

Solve Equation 5.1 with the FDM using the estimated values o f
A

P-{D v A}

^

and compute T, the estimated concentration obtained from

the solution o f the direct problem by using the estimated values o f the
unknown parameters.
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Solve Equation 5.1 with the FDM two more times with different
parameters
T ( D X + A D , , D 2)
T ( D | , D j + A D 2)

Compute the sensitivity coefficients matrix J using the solution from
step

1 and

2.

For

example,

with

respect

to

D,

we

have

dTt _ r(A + A D 1, p 2) - :r ( A > A )

5D,

AD,

4.

Calculate ( J TJ + j u j y 1J T(Y - T )

5.

A*+1
Calculate p

6.

Restart from

step

1 until the

following criterion

is

satisfied

S k+X- S k
< \E -5

5.4.4.5 Check on the Diffusion Model. Mass balance was applied to check on the
accuracy o f the diffusion model. The estimation o f core diffusivity and membrane
diffusivity were obtained from the diffusion model. Using these estimates the total mass
in the whole bulk area was calculated at different time steps. If the model is correct, one
expects the total mass to remain constant over time. The Figure 5.1 is the total mass over
time when I s p e c ify ^ ~ 18.7/fln l h r , D 2 = 5.9 x 10 pm I hr jt -s seen from Figure 5.2
that, in fact, the total mass remains constant which indicates that the model is accurate.
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Figure 5.2. Total mass in the bulk over time
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CHAPTER 6

RESULTS AND DISCUSSION OF
TRANSPORT PHENOMENA

6.1 Introduction
At the Institute for Micromanufacturing (IfM), Louisiana Tech University, poly
(styrene sulfonate) (PSS), poly (vinylsulfat) (PVS), poly (allylamine) (PAH) and poly
(diallyldimethylammonium) (PDDA) are the four polyelectrolytes used in layer-by-layer
encapsulation o f microsphere colloidal core material (melamine formal dehyde (MF)) to
obtain multilayer microcapsules. A permeability comparison for different layers o f
PSS/PAH, PVS/PAH, PSS/PDDA and PVS/PDDA was made using 4000 MW or 7700
MW FITC-dextran loaded for 12h, 36h or 60h.

6.2 Comparisons of Experimental
Data and Model Results
In fitting the model to the experimental observations, the radius o f the bulk liquid,
R, was taken to be 18.6 fim. This was determined from the ratio o f the volume o f the
microcapsules in solution to the volume o f the bulk solution. This ratio (estimated as
0.002439 from experimental conditions) is equal to

55
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Ratio = —— ^— -----1 ^ ’- V
3
3

(6.1)

where /??is the radius o f the microcapsule and is equal to 2 .5 / m .
Comparisons o f the experimental data and model results are shown in Figures.
6.1-6.47. The experimental data are the normalized concentration o f dextran in the bulk
liquid over time, recorded as the average o f three measurements. The model results are
the predicted values from the finite difference release phenomena model. It is seen from
these figures that, in general, there is a very good fit o f the model to the experimental
observations.
The parameters D ] and D 2 were estimated from fitting the model to the
experimental data. The parameter D3, is known and represents the diffusivity o f dextran
in water which was taken to be 6.28 x 105/ m 2 / h r .
Figure 6.1 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading time=12h, MW=4000. Sum o f square error, SSE=0.067.
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Figure 6 .1. Psspah41240 predicted and observed normalized concentration o f dextran

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

57
Figure 6.2 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading time=12h, MW=77000. Sum o f square error, SSE=0.056.
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Figure 6.2. Psspah41277 predicted and observed normalized concentration o f dextran

Figure 6.3 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading time=36h, MW=4000. Sum o f square error, SSE=0.059625.
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Figure 6.3. Psspah43640 predicted and observed normalized concentration o f dextran
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Figure 6.4 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading tim e ^ b h , M W -77000. Sum o f square error, SSE=0.03471.
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Figure 6.4. Psspah43677 predicted and observed normalized concentration o f dextran

Figure 6.5 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading time=60h, MW=4000. Sum o f square error, SSE=0.004871.
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Figure 6.5. Psspah46040 predicted and observed normalized concentration o f dextran
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Figure 6.6 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading time=60h, MW=77000. Sum o f square error, SSE=0.002657.
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Figure 6.6. Psspah46-77 predicted and observed normalized concentration o f dextran

Figure 6.7 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=12h, MW=4000. Sum o f square error, SSE=0.007494.
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Figure 6.7. Pvspah41240 predicted and observed normalized concentration o f dextran
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Figure 6.8 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=36h, MW=4000. Sum o f square error, SSE=0.0757.
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Figure 6.8. Pvspah43640 predicted and observed normalized concentration o f dextran

Figure 6.9 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=36h, MW=77000. Sum o f square error, SSE=0.002008.
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Figure 6.9. Pvspah43677 predicted and observed normalized concentration o f dextran
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Figure 6.10 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=60h, MW=4000. Sum o f square error, SSE=0.04956.
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Figure 6.10. Pvspah46040 predicted and observed normalized concentration o f dextran

Figure 6.11 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=60h, MW=77000. Sum o f square error, SSE=0.030535.

pvspah46077

• •

3 0-6

*¥

H

0.8

♦ ex p
■ model

I 04

|

0.2

I

o
0

20

40

60

80

100

120

tim e (h )

Figure 6.11. Pvspah46077 predicted and observed normalized concentration o f dextran
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Figure 6.12 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.00247.
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Figure 6.12. Psspdda41240 predicted and observed normalized concentration o f dextran

Figure 6.13 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.054048.
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Figure 6.13. Psspdda23640 predicted and observed normalized concentration o f dextran
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Figure 6.14 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.032675.
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Figure 6.14. Psspdda26040 predicted and observed normalized concentration o f dextran

Figure 6.15 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.018417.
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Figure 6.15. Psspdda21277 predicted and observed normalized concentration o f dextran
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Figure 6.16 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=36h, MW -77000. Sum o f square error, SSE=0.057577.
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Figure 6.16. Psspdda23677 predicted and observed normalized concentration o f dextran

Figure 6.17 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.049597.
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Figure 6.17. Psspdda26077 predicted and observed normalized concentration o f dextran
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Figure 6.18 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.009251.
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Figure 6.18. Psspdda41240 predicted and observed normalized concentration o f dextran

Figure 6.19 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.015766.
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Figure 6.19. Psspdda43640 predicted and observed normalized concentration o f dextran
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Figure 6.20 shows predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.238115.
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Figure 6 .20. Psspdda46040 predicted and observed normalized concentration o f dextran

Figure 6.21 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading tim e-12h, MW=77000. Sum o f square error, SSE=0.014435.
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Figure 6.21. Psspdda41277 predicted and observed normalized concentration o f dextran
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Figure 6.22 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.012.
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Figure 6.22. Psspdda43677 predicted and observed normalized concentration o f dextran

Figure 6.23 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.026.
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Figure 6 .23. Psspdda46077 predicted and observed normalized concentration o f dextran
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Figure 6.24 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.025808.
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Figure 6.24. Psspdda61240 predicted and observed normalized concentration o f dextran

Figure 6.25 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.024.
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Figure 6.25. Psspdda63640 predicted and observed normalized concentration o f dextran
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Figure 6.26 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.036.

psspdda66040
g 12

I

1

§

0.8

■**

♦ exp

8 0.6

■ m o d el

I 04
I 0.2

5

-i----------------- 1
----------------- 1
----------------- r*

0
0

10

20

30

40

50

time(h)

Figure 6.26. Psspdda66040 predicted and observed normalized concentration o f dextran

Figure 6.27 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.014997.
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Figure 6.27. Psspdda61277 predicted and observed normalized concentration o f dextran
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Figure 6.28 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.034.
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Figure 6.28. Psspdda63677 predicted and observed normalized concentration o f dextran

Figure 6.29 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.36.
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Figure 6.29. Psspdda66077 predicted and observed normalized concentration o f dextran
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Figure 6.30 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.010652.
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Figure 6.30. Pvspdda21240 predicted and observed normalized concentration o f dextran

Figure 6.31 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.065815.
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Figure 6.31. Pvspdda21277 predicted and observed normalized concentration o f dextran
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Figure 6.32 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SS E -0.003324.
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Figure 6.32. Pvspdda23640 predicted and observed normalized concentration o f dextran

Figure 6.33 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.011105.
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Figure 6.33. Pvspdda23677 predicted and observed normalized concentration o f dextran
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Figure 6.34 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is tw o layers o f
PVS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.015402.
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Figure 6.34. Pvspah26040 predicted and observed normalized concentration o f dextran

Figure 6.35 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.034494.
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Figure 6.35. Pvspdda26077 predicted and observed normalized concentration o f dextran
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Figure 6.36 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.00472.
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Figure 6.36. Pvspdda41240 predicted and observed normalized concentration o f dextran

Figure 6.37 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.004604.
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Figure 6.37. Pvspdda43640 predicted and observed normalized concentration o f dextran
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Figure 6.38 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.011997.
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Figure 6.38. Pvspdda46040 predicted and observed normalized concentration o f dextran

Figure 6.39 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.022496.
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Figure 6.39. Pvspdda41277 predicted and observed normalized concentration o f dextran
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Figure 6.40 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.014.
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Figure 6.40. Pvspdda43677 predicted and observed normalized concentration o f dextran

Figure 6.41 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.003661.
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Figure 6.41. Pvspdda46077 predicted and observed normalized concentration o f dextran
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Figure 6.42 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.04102.
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Figure 6.42. Pvspdda61240 predicted and observed normalized concentration o f dextran

Figure 6.43 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.013186.
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Figure 6.43. Pvspdda61277 predicted and observed normalized concentration o f dextran
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Figure 6.44 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.008347.
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Figure 6.44. Pvspdda63640 predicted and observed normalized concentration o f dextran

Figure 6.45 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.038904.
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Figure 6.45. Pvspdda63677 predicted and observed normalized concentration o f dextran
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Figure 6.46 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.00288.
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Figure 6.46. Pvspdda66040 predicted and observed normalized concentration o f dextran

Figure 6.47 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.022259.
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Figure 6.47. Pvspdda66077 predicted and observed normalized concentration o f dextran
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6.3 Estimates of Microcapsule Core and
Wall Membrane Diffusion Coefficients
Estimates o f the diffusivity in the core o f the microcapsule (D l) and in the wall
membrane (D2) were obtained from fitting the model to the experimental data as shown
in Figures. 6.1-6.47. Table 6.1 gives these estimates for different types o f membranes,
loading times, molecular weights, and layer thickness. The unit o f the diffusion
coefficient (D l and D2) is in ftm2 per hour.

Table 6.1. Estimates o f the diffusion coefficients in D l (the core o f the microcapsule) and
in D2 (the wall membrane)
psspdda
D1 =
D2=
SSE=

21240
10.168659
1.64E-05
0.0024743

23640
24.8381887
4.82E-06
0.0540485

26040
18.562249
4.20E-06
0.0326746

21277
23.951496
7.50 E-06
0.0184165

23677
24.900449
4.79E-06
0.0575772

26077
20.509278
3.53 E-06
0.0495965

psspdda
D1 =
D2=
SSE=

41240
8.5991903
7.89E-06
0.0092506

43640
6.04202352
3.73E-06
0.01576627

46040
8.0807803
4.02 E-06
0.2381145

41277
9.5221096
5.99E-06
0.0144352

43677
4.8
3.40E-06
0.012

46077
4.7
3.30E-06
0.026

psspdda
D1 =
D2=
SSE=

61240
13.591459
3.81 E-06
0.0258080

63640
10.2
4.80E-06
0.024

66040
10.5
3.40E-06
0.036

61277
15.199701
7.75E-06
0.0149972

63677
11.4
4.50 E-06
0.034

66077
11
1.80E-06
0.36

pvspdda
D1 =
D2=
SSE=

21240
13.288079
1.17E-05
0.0106521

23640
11.0090987
2.67E-06
0.00332407

26040
10.688615
2.32 E-06
0.0154420

21277
18.676951
8.22 E-06
0.0658148

23677
10.709831
3.13E-06
0.0111052

26077
9.8895273
3.34E-06
0.0344934

pvspdda
D1 =
D2=
SSE=

41240
10.671604
5.05E-06
0.0047195

43640
10.9032036
3.43E-06
0.00460433

46040
10.806467
3.29E-06
0.0119969

41277
10.224095
5.06E-06
0.0224955

43677
10.968331
2.19E-06
0.0013996

46077
10.461454
1.75E-06
0.0036612

pvspdda
D1 =
D2=
SSE=

61240
9.3441210
5.27E-06
0.0410197

63640
10.7027215
3.14E-06
0.00834733

66040
10.964211
2.94E-06
0.0028802

61277
10.142274
7.95E-06
0.0131864

63677
10.248225
3.60E-06
0.0389037

66077
10.486949
2.70E-06
0.0222586
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psspah
D1 =
D2=
SSE=

41240
1.94E+02
2.10E-05
0.067

43640
6.553579
3.15E-06
0.059625

46040
6.423386
3.50 E-06
0.004871

41277
6.70E+00
4.20E-06
0.056

43677
7.574897
3.74E-06
0.03471

46077
6.388522
3.11 E-06
0.002657

pvspah
D1 =
D2=
SSE=

41240
18.42723
1.46E-05
0.007494

43640
9.060798
4.02E-06
0.075704

46040
7.467331
3.82E-06
0.04956

41277

43677
6.792011
4.28E-06
0.002008

46077
4.64723
3.46E-06
0.030535

In order to determine the main effects o f membrane type, loading time, dextran
molecular weight, and number o f layers in the wall membrane on the diffusivity
coeffiecients D l and D2, an anlysis o f variance was performed on the portion o f the data
in Table 6.1 that includes psspdda and pvspdda. This excluded psspah and pvspah since
this data set was only for four layers. Results o f the analysis o f variance for D l are
presented in Table 6.2.

Table 6.2. Analysis o f variance for D l (the microcapsule core diffusivity)
S o u rc e

DF

T y p e III S S

M ean S q u are

F V alu e

Pr > F

ty p e

1

3 6 .7 6 3 6 5 3 4

3 6 .7 6 3 6 5 3 4

2 .3 9

0 .1 3 3 0

lay er

2

3 6 5 .5 9 9 0 9 6 6

1 8 2 .7 9 9 5 4 8 3

1 1 .8 8

0 .0 0 0 2

tim e

2

11 .8 2 4 4 6 0 6

5 .9 1 2 2 3 0 3

0 .3 8

0 .6 8 4 4

mw

1

9 .8 4 9 1 3 9 2

9 .8 4 9 1 3 9 2

0 .6 4

0 .4 3 0 2

From the p values in Table 6.2, it is seen that only layer number has a significant
effect on D l. Table 6.3 gives pair-wise mean comparisons among the layer means. It is
seen from the p values in the table that D l is significantly larger for two layers than for
four layers. However, there is no difference in the D l diffusivity between four and six
layers.
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Table 6.3. Pair-wise comparisons among the layer means for D l
lay er

2

D1 MEAN

N u m b er

16.4327021 E -6

1

4

8 .8 1 4 9 3 8 3 E -6

2

6

1 1 .1 4 8 3 0 5 4 E -6

3

D e p e n d e n t V ariable: D1
i/j

1

1

2

3

0.0001

2

0.0001

3

0 .0 0 7 0

0 .0 0 7 0
0 .3 2 5 9

0 .3 2 5 9

1.80E-05
1.60E-05 4
1.40E-05
1.20E-05
c
TO 1.00E-05 4®
E

8.00E-06
6.00E-06
4.00E-06 4
2.00E-06
0.00E+00
layer number

Figure 6.48. Plot o f the mean o f D l against layer number

The plot in Figure 6.48 shows that the mean diffusivity in the core decreases from
two to four layers, but the difference between four and six is not significant as indicated
in Table 6.3.
The same analysis o f variance for diffusivity (D2) in the wall membrane is
presented in Table 6.4.
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Table 6.4. Analysis o f variance for D2 (wall membrane diffusivity)
S o u rc e

DF

M ean S q u a r e

T y p e III S S

F V alu e

Pr > F

ty p e

1

8 .8 8 0 4 E -1 2

8 .8 8 0 4 E -1 2

2.4 7

0 .1 2 7 0

lay er

2

2.7751 E-11

1.387591 E-11

3 .8 6

0 .0 3 2 7

tim e

2

1 .5 3 7 6 4 E -1 0

7 .6 882E -11

2 1 .3 7

<.0001

mw

1

4 .2 5 7 3 4 4 E -1 2

4 .2 5 7 3 4 4 E -1 2

1.18

0 .2 8 5 7

It is seen from the p values in the table that both layer and time have significant
effects on D2. The pair-wise mean comparisons in Table 6.5 show that D2 decreased
significantly with an increase in the number o f layers from two to four. However, the
difference in diffusivity between four and six layers was not significant. These results are
shown graphically in Figure 6.49. From the pair-wise mean comparisons among the D2
means for the different loading times (Table 6.6), it is seen that D2 decreased
significantly from two to four layers. However, the decrease in D2 as the number o f
layers increased from four to six was not significant. These results are shown graphically
in Figure 6.50.

Table 6.5. Pair-wise comparisons among the layer means for D2
la y e r

D2 MEAN

N u m b er

2

6 .0 5 1 6 6 6 7 E -6

1

4

4 .0 9 1 6 6 6 7 E -6

2

6

4 .3 0 5 E -6

3

D e p e n d e n t V ariable: D2

i/j

1

1

2

0 .0 4 3 7

2

0 .0 4 3 7

3

0 .0 7 8 6

3

0 .0 7 8 6
0.9591

0.9591
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9.00E-06
8.00E-06
7.00E-06
6.00E-06
re 5.00E-06 4
0)
E 4.00E-06 —
CM
c

O

3.00E-06
2.00E-06------1.00E-06
0.00E+00
layer number

Figure 6.49. Plot of the mean o f D2 against layer number

Table 6.6. Pair-wise comparisons among the loading time means for D2
tim e

D2 MEAN

N um ber

12

7 .7 1 5 8 3 3 3 E -6

1

36

3 .6 8 3 3 3 3 3 E -6

2

60

3 .0 4 9 1 6 6 7 E -6

3

D e p e n d e n t V ariab le: D2

1

<.0001

2

<.0001

3

<.0001

<.0001
0 .6 9 4 5

0 .6 9 4 5
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9.00E-06
8.00E-06
7.00E-06

cn
®

6.00E-06
5.00E-06

E

<N 4.00E-06
Q

3.00E-06

2.00E-06
1.00E-06
O.OOE+OO
36

12

60

loading time

Figure 6.50. Plot o f the mean o f D2 against loading time

In order to determine the effect o f layer type on diffusivity where all four types
are present, an analysis o f variance on D l and D2 was performed using the data for four
layers in Table 6.1. It is seen from the p values in Table 6.7 that membrane or layer type,
loading time, and dextran molecular weight have no effect on diffusivity through the core
of the microcapsule.

Table 6.7. Analysis o f variance for D l o f data set two
S o u rc e

DF

T y p e III S S

M e an S q u a r e

F V alue

ty p e

Pr > F

3

2 .8 0 1 755E -11

9 .3 3 9 1 8 2 E -1 2

0 .7 6

0 .5 3 2 5

tim e

2

1 .3 0 1 3 8 1 E-10

6 .5 0 6 9 0 6 E -1 1

5 .3 0

0.0171

mw

1

5 .2 5 8 0 3 9 E -1 1

5 .2 5 8 0 3 9 E -1 1

4 .2 8

0.0551

From the p values in Table 6.8, it is seen that molecular weight and loading time

have significant effects on diffusivity in the wall membrane (D2). From the p values in
Table 6.9, it is seen that the diffusivity in the wall membrane is larger for 12 hours o f
loading time than for 36 or 60 hours. Diffusivity for 36 hours o f loading time is not
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significantly different from that for 60 hours. These results are shown graphically in
Figure 6.51.

Table 6.8 Analysis o f variance for D2 o f data set two
S o u rc e

DF

T y p e III S S

M e an S q u a r e

F V alu e

Pr>F

ty p e

3

4 1 0 1 .3 1 8 7 1 6

1 3 6 7 .1 0 6 2 3 9

0 .9 2

0 .4 5 2 5

tim e

2

3 8 4 8 .1 5 0 3 7 3

1 9 2 4 .0 7 5 1 8 7

1.30

0 .3 0 0 3

mw

1

2 0 1 4 .1 6 3 4 7 5

2 0 1 4 .1 6 3 4 7 5

1.36

0 .2 6 0 8

Table 6.9. Pair-wise comparisons among the D2 means o f data set two for loading time
tim e

D2 MEAN

12

N u m b er

8 .3 4 5 E -6

1

36

3 .3 0 4 5 5 8 8 E -6

2

60

3 .3 6 8 7 5 E -6

3

D e p e n d e n t V ariab le: D2
i/j

1
1

2

3
0 .0 3 5 4

2

0 .0 3 5 4

3

0.0301

0.0301
0 .9 9 9 3

0 .9 9 9 3

9.00E-06
8.00E-06 -t 7.00E-06
6.00E-06
2

5.00E-06

^

4.00E-06 -

°

3.00E-06
2.00E-06

y-. " *- K

1.00E-06

;

0.00E+00

12

36

60

loading time

Figure 6.51. Plot o f the mean o f D2 o f data set two against loading time
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It is seen from Table 6.10 that the diffusivity through the wall membrane is
smaller for 77000 dextran molecular weight than for 4000 molecular weight. The
decrease in diffusivity with an increase in molecular weight is shown graphically in
Figure 6.52.

Table 6.10. Mean diffusivity in the membrane wall for 4000 and 77000 dextran
molecular weights
mw

D2 MEAN

4000

6 .5 2 9 1 6 6 7 E -6

77000

3 .4 8 3 0 3 9 2 E -6

P r > |t|

0.0551

7.00E-06
6.00E-06
5.00E-06
JJJ 4.00E-06
N

3.00E-06
2.00E-06
1.00E-06
0.00E+00
4000

77000
molecular weight

Figure 6.52. Plot o f the mean o f D2 o f data set two against weight

6.4 Conclusion
From the analysis o f variance in Tables 6.2 and 6.3, it is seen that only layer

thickness had an effect on diffusivity in the core. The diffusivity for four layers was
almost half o f that for two layers o f polyelectrolytes in the core. In the case o f diffusivity
in the microcapsule wall, both time and layer thickness had an effect (Tables 6.4 and 6.5).
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In this case, diffusivity was larger for two layers o f wall membrane thickness than for
four or six layers and it was also larger for 12 hours than for 36 or 60 hours o f loading
time. There was no significant change in diffusivity beyond four layers or beyond 36
hours o f loading time. From Tables 6.8 - 6.10, it is interesting to see that for four layers
o f wall membrane thickness molecular weight had an effect on diffusivity through the
wall membrane with the high molecular weight diffusing more slowly than the low
molecular weight. In all analyses, membrane type had no marginal effect on diffusivity
when considered over all loading times, membrane thickness, and molecular weight.

6.5 F u tu re W ork
In the future work, it would be o f interest to modify the diffusion model to include
only the release stage and apply it to data where dextran is initially encapsulated in the
core. In this case, one may gain a clearer insight about the nature o f diffusivity inside the
core and wall membrane o f the microcapsules.
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